Author(s): Paraskevas KI, Mikhailidis DP
Abstract Share this page
Abstract This editorial discusses whether measuring C-reactive protein (CRP) levels can be used as a predictor of vascular risk. The agents that reduce CRP levels and the evidence for a possible causative role of CRP in the pathogenesis of coronary events and atherosclerosis are also considered. There is a need to further elucidate the role of CRP, as well as the clinical relevance, if any, of CRP-lowering agents.
This article was published in Curr Med Res Opin
and referenced in Journal of Antivirals & Antiretrovirals